Loperamide toxicity: Difference between revisions

Line 19: Line 19:


==Management==
==Management==
*Supportive care / standard [[ACLS]]
*Consider:
**[[Overdrive pacing]]
**[[Intravenous lipid emulsion]]
**[[Extracorporeal membrane oxygenation]]


==Disposition==
==Disposition==

Revision as of 07:20, 14 August 2017

Background

  • Increasing reports of intentional overdose at very high doses either for euphoric effects or to attenuate symptoms of opioid withdrawal[1]

Clinical Features

Loperamide-induced cardiac toxicity[2]

  • Often young
  • May present in cardiac arrest or with recurrent syncope in conjunction with ECG agnormalities

Differential Diagnosis

Sedative/hypnotic toxicity

Evaluation

ECG Findings

Management

Disposition

See Also

External Links

References

  1. Wu PE, et al. "Clinical Review: Loperamide Toxicity." Annals of EM. August 2017. 70(2):245-252
  2. Wu PE, et al. "Clinical Review: Loperamide Toxicity." Annals of EM. August 2017. 70(2):245-252